Treatments for metastatic hormone-sensitive prostate cancer have remained the same for seventy years – until now. Scientists have created a medication, called Nubeqa, that pairs with the original treatments and helps lengthen the lifespan of patients. An expert discusses why this is an optimistic time for MHSPC patients.

Learn more: https://radiohealthjournal.org/a-new-hope-for-men-with-advanced-prostate-cancer/

Facebook: ingoodhealthpod

X: @ ingoodhealthpod

IG: @ingoodhealthpod
YouTube: @ingoodhealthpod

Spotify 

Apple Podcast 

In Good Health Podcast

Subscribed to the newsletter

Full Archive

Contact Us

Become an Affiliate

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.